Chemodectomas of the Middle Ear: A Comparison of Therapeutic Modalities
- 1 November 1973
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 98 (5) , 330-335
- https://doi.org/10.1001/archotol.1973.00780020342013
Abstract
Thirty-three cases of chemodectoma are presented, with patients staged in three groups: tympanic (1), tympanomastoid (2), and petrosal-extrapetrosal (3). Surgery is effective in group 1 cases.Surgery and moderate-dose postoperative cobalt irradiation (3,500 to 4,000 rads in three weeks) are used for more advanced lesions with higher-dose irradiation (5,000 to 5,500 rads in five weeks) reserved for very extensive tumors. Overall control of tumor in these cases is 84% in follow-ups from 1 to 31 years.Keywords
This publication has 17 references indexed in Scilit:
- Non-chromaffin ParagangliomaPublished by Springer Nature ,2013
- CHEMODECTOMAS OF THE HEAD AND NECKAmerican Journal of Roentgenology, 1970
- Metastases of Glomus Jugulare TumorsJAMA Otolaryngology–Head & Neck Surgery, 1965
- A comprehensive study of tumors of the glomus jugulare.The Laryngoscope, 1962
- Tumors of the glomus jugularis: A report of nine casesThe Laryngoscope, 1959
- Chemodectoma or Tumor of the Glomus Jugulare and Tympanic BodiesA.M.A. Archives of Otolaryngology, 1958
- Metastasis from Glomus Jugulare Tumors: Discussion of Nomenclature and TherapyJAMA Otolaryngology–Head & Neck Surgery, 1958
- XCII The Glomus Jugulare, a Nonchromaffin Paraganglion, in ManAnnals of Otology, Rhinology & Laryngology, 1953
- Nonchromaffin paraganglioma of ganglion nodosum, carotid body, and aortic-arch bodiesCancer, 1950
- CAROTID BODY TUMOR OF THE MIDDLE EAR AND MASTOIDJAMA Otolaryngology–Head & Neck Surgery, 1945